Workflow
P/E ratio
icon
Search documents
SYIEY vs. GVDNY: Which Stock Is the Better Value Option?
ZACKS· 2026-01-08 17:40
Investors with an interest in Chemical - Specialty stocks have likely encountered both Symrise AG Unsponsored ADR (SYIEY) and Givaudan SA (GVDNY) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Sco ...
RIO vs. WPM: Which Stock Is the Better Value Option?
ZACKS· 2026-01-07 17:41
Investors with an interest in Mining - Miscellaneous stocks have likely encountered both Rio Tinto (RIO) and Wheaton Precious Metals Corp. (WPM) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style ...
ACI or CL: Which Is the Better Value Stock Right Now?
ZACKS· 2026-01-06 17:41
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Albertsons Companies, Inc. (ACI) or Colgate-Palmolive (CL) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates ...
QSR vs. CMG: Which Stock Should Value Investors Buy Now?
ZACKS· 2025-12-30 17:40
Investors looking for stocks in the Retail - Restaurants sector might want to consider either Restaurant Brands (QSR) or Chipotle Mexican Grill (CMG) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targ ...
ETOR or AON: Which Is the Better Value Stock Right Now?
ZACKS· 2025-12-30 17:40
Investors interested in Insurance - Brokerage stocks are likely familiar with eToro Group Ltd. (ETOR) and Aon (AON) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our ...
PFSI or ZG: Which Is the Better Value Stock Right Now?
ZACKS· 2025-12-23 17:41
Core Viewpoint - PennyMac Financial (PFSI) is currently viewed as a better value opportunity compared to Zillow Group (ZG) based on various financial metrics and analyst outlooks [1]. Group 1: Zacks Rank and Analyst Outlook - PFSI has a Zacks Rank of 2 (Buy), indicating a strong earnings estimate revision trend, while ZG has a Zacks Rank of 3 (Hold) [3]. - The improving analyst outlook for PFSI suggests a more favorable investment environment compared to ZG [3]. Group 2: Valuation Metrics - PFSI has a forward P/E ratio of 11.48, significantly lower than ZG's forward P/E of 40.74, indicating that PFSI may be undervalued [5]. - The PEG ratio for PFSI is 0.80, while ZG's PEG ratio is 1.28, suggesting that PFSI offers better value relative to its expected earnings growth [5]. - PFSI's P/B ratio is 1.66, compared to ZG's P/B of 3.3, further supporting the argument that PFSI is more attractively valued [6]. Group 3: Overall Conclusion - Stronger estimate revision activity and more attractive valuation metrics position PFSI as the superior option for value investors at this time [7].
ETOR or MMC: Which Is the Better Value Stock Right Now?
ZACKS· 2025-12-11 17:41
Core Viewpoint - The article compares eToro Group Ltd. (ETOR) and Marsh & McLennan (MMC) to determine which stock is a better undervalued investment option for investors in the Insurance - Brokerage sector [1] Group 1: Zacks Rank and Earnings Outlook - eToro Group Ltd. has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Marsh & McLennan has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank system emphasizes companies with positive earnings estimate revisions, suggesting that ETOR has an improving earnings outlook [3][6] Group 2: Valuation Metrics - ETOR has a forward P/E ratio of 15.62, compared to MMC's forward P/E of 18.83, indicating that ETOR may be undervalued relative to MMC [5] - The PEG ratio for ETOR is 2.15, while MMC's PEG ratio is 3.11, further suggesting that ETOR has a more favorable valuation considering expected EPS growth [5] - ETOR's P/B ratio is 2.42, significantly lower than MMC's P/B of 5.77, reinforcing the notion that ETOR is a better value option [6] Group 3: Value Grades - Based on various valuation metrics, ETOR has earned a Value grade of A, while MMC has a Value grade of D, indicating that ETOR is currently viewed as the superior value investment [6]
CPRX or DSNKY: Which Is the Better Value Stock Right Now?
ZACKS· 2025-12-01 17:48
Core Viewpoint - Investors in the Medical - Drugs sector should consider Catalyst Pharmaceutical (CPRX) as a more attractive investment opportunity compared to Daiichi Sankyo Co., Ltd. (DSNKY) based on current valuation metrics and analyst outlook [1][3][7] Valuation Metrics - Catalyst Pharmaceutical has a forward P/E ratio of 9.66, significantly lower than Daiichi Sankyo's forward P/E of 20.22, indicating that CPRX may be undervalued [5] - The PEG ratio for CPRX is 0.82, suggesting better expected earnings growth relative to its price compared to DSNKY's PEG ratio of 1.18 [5] - CPRX's P/B ratio stands at 3.11, while DSNKY has a higher P/B ratio of 4.28, further supporting the notion that CPRX is more attractively valued [6] Analyst Outlook - Catalyst Pharmaceutical holds a Zacks Rank of 2 (Buy), reflecting positive earnings estimate revisions and a favorable analyst outlook, whereas Daiichi Sankyo has a Zacks Rank of 5 (Strong Sell) [3][7] - The stronger estimate revision activity for CPRX indicates a more optimistic future performance compared to DSNKY [7]
CUZ vs. EGP: Which Stock Is the Better Value Option?
ZACKS· 2025-11-28 17:41
Core Insights - Investors in the REIT and Equity Trust - Other sector should consider Cousins Properties (CUZ) and EastGroup Properties (EGP) for potential undervalued stock opportunities [1] Valuation Metrics - Cousins Properties has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while EastGroup Properties has a Zacks Rank of 4 (Sell) [3] - CUZ has a forward P/E ratio of 9.08, significantly lower than EGP's forward P/E of 20.23, suggesting CUZ may be undervalued [5] - The PEG ratio for CUZ is 2.04, compared to EGP's PEG ratio of 2.73, indicating CUZ has a more favorable earnings growth outlook relative to its valuation [5] - CUZ's P/B ratio is 0.91, while EGP's P/B ratio is 2.75, further supporting the argument that CUZ is undervalued [6] - Overall, CUZ has a Value grade of B, while EGP has a Value grade of D, highlighting CUZ's stronger valuation metrics [6] Conclusion - Given the stronger estimate revision activity and more attractive valuation metrics, CUZ is positioned as the superior option for value investors compared to EGP [7]
AMG vs. ARES: Which Stock Is the Better Value Option?
ZACKS· 2025-11-24 17:40
Core Insights - The article compares Affiliated Managers Group (AMG) and Ares Management (ARES) to identify which company presents a better investment opportunity for undervalued stocks [1] Group 1: Zacks Rank and Earnings Outlook - AMG has a Zacks Rank of 2 (Buy), indicating a more favorable earnings estimate revision trend compared to ARES, which has a Zacks Rank of 3 (Hold) [3] - The improving analyst outlook for AMG suggests a positive earnings estimate revision activity [3][7] Group 2: Valuation Metrics - AMG's forward P/E ratio is 10.22, significantly lower than ARES's forward P/E of 29.04, indicating that AMG may be undervalued [5] - AMG has a PEG ratio of 0.57, while ARES has a PEG ratio of 1.14, further suggesting that AMG is a better value option based on expected earnings growth [5] - AMG's P/B ratio is 1.71, compared to ARES's P/B of 6.74, reinforcing AMG's position as a more attractive investment based on market value versus book value [6] - These metrics contribute to AMG's Value grade of A and ARES's Value grade of C [6]